In search of better specificity and lower chances of resistance, protease-activatable alkoxyamine prodrugs to fight cancer have been proposed. These molecules are made of a peptide linked to an alkoxyamine. Proteolysis of the peptide converts the stable prodrug at 37 °C to a metastable alkoxyamine that spontaneously homolyzes into two free radicals: a stable nitroxide and a very reactive alkyl radical.
View Article and Find Full Text PDFIonizing radiation induced transformations in materials were monitored through tracking of the generation and degradation processes of radical species. Consequently, the types and quantities of radicals were determined by electron spin resonance (ESR). Subsequently, differential scanning calorimetry (DSC) was utilized to assess the impact of irradiation on the material crystallinity.
View Article and Find Full Text PDFThe expansion of drug resistant parasites sheds a serious concern on several neglected parasitic diseases. Our recent results on cancer led us to envision the use of peptide-alkoxyamines as a highly selective and efficient new drug against schistosome adult worms, the etiological agents of schistosomiasis. Indeed, the peptide tag of the hybrid compounds can be hydrolyzed by worm's digestive enzymes to afford a highly labile alkoxyamine which homolyzes spontaneously and instantaneously into radicals-which are then used as a drug against Schistosome adult parasites.
View Article and Find Full Text PDF